DrugPatentWatch Database Preview
Generic Companies with Tentative Approvals for: Watson Labs
» See Plans and Pricing
Watson Labs Generic Filers with Tentative Approvals
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Applicant | Generic Name | NDA | Strength | Dosage Form |
---|---|---|---|---|
Watson Labs Inc | sitagliptin phosphate | 202327 | 50MG | TABLET;ORAL |
Watson Labs Inc | rosuvastatin zinc | 202172 | 5MG | TABLET; ORAL |
Watson Labs Inc | bupropion hydrobromide | 200835 | 174MG | TABLET, EXTENDED RELEASE; ORAL |
Watson Labs Florida | telmisartan; hydrochlorothiazide | 091084 | 40MG; 12.5MG | TABLET; ORAL |
>Applicant | >Generic Name | >NDA | >Strength | >Dosage Form |